Loading clinical trials...
Loading clinical trials...
This is a multicenter, randomized, placebo-controlled, double-blind study to evaluate the safety and immunogenicity of a 2-injection vaccine Chikungunya virus (CHIKV) virus-like particle vaccine (CHIK...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NCT07520279 · Malaria Fever, Zika, and more
NCT03483961 · Chikungunya Virus Infection
NCT03807843 · Chikungunya Virus Infection
NCT02861586 · Chikungunya Virus Infection
NCT03028441 · Chikungunya Virus Infection
Instituto Dermatológico y Cirugía de Piel
Santo Domingo
University Hospital of Pointe-à-Pitre
Pointe-à-Pitre
Centres GHESKIO
Port-au-Prince
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions